参考文献/References:
[1] 叶波,杨龙海,刘向阳.最新国际肺癌TNM分期标准(第7版)修订稿解读.中国医刊,2008,43(1):21-23.
[2] Cyr JE, Pearson DA, Nelson CA, et al. Isolation, characterization, and biological evaluation of syn and anti diastereomers of[(99m) Tc]technetium depreotide:a somatostatin receptor binding tumor imaging agent. J Med Chem, 2007, 50(18):4295-4303.
[3] Shih WJ, Samayoa L. Tc-99m depreotide detecting malignant pulmonary nodules:histopathologic correlation with semiquantitative tumor-to-normal lung ratio. Clin Nucl Med, 2004, 29(3):171-176.
[4] Alzahouri K, Vehen M, Arveux P, et al. Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule:a multicentre study in 18 French districts. BMC Cancer, 2008, 8:93.
[5] Winer-Muram HT. The solitary pulmonary nodule. Radiology, 2006, 239(1):34-49.
[6] Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med, 2003, 348(25):2535-2542.
[7] Ambrosini V, Rubello D. Is there an ideal diagnostic algorithm in solitary pulmonary nodules?. Respiration, 2006, 73(5):587-589.
[8] Diederich S, Das M. Solitary pulmonary nodule:detection and management. Cancer Imaging, 2006, 6(Spec No A):S42-S46.
[9] Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer:suspiciousness of nodules according to size on baseline scans. Radiology, 2004, 231(1):164-168.
[10] Orlacchio A, Schillaci O, Antonelli L, et al. Solitary pulmonary nodules:morphological and metabolic characterisation by FDGPET-MDCT. Radiol Med, 2007, 112(2):157-173.
[11] Kim SK, Allen-Auerbach M, Gotdin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med, 2007, 48(2):214-220.
[12] Cronin P, Dwamena BA, Kelly AM, et al. Solitary pulmonary nodules:meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology, 2008, 246(3):772-782.
[13] Halley A, Hugentobler A, Icard P, et al. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging, 2005, 32(9):1026-1032.
[14] Naalsund A, Maublant J. The solitary pulmonary nodule-is it malignant or benign? Diagnostic performance of 99mTc-depreotide SPECT. Respiration, 2006, 73(5):634-641.
[15] Plachcinska A, Mikolajczak R, Maecke H, et al. Efficacy of 99mTc-EDDA/HYNIC-TOC scintigraphy in differential diagnosis of solitary pulmonary nodules. Cancer Biother Radiopharm, 2004, 19(5):613-620.
[16] Plachcinka A, Mikolajczak R, Kozak J, et al. Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules. Nucl Med Rev Cent East Eur, 2006, 9(1):24-29.
[17] Axelsson R, Herlin G, Baath M, et al. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer. Acta Radiol, 2008, 49(3):295-302.
[18] Boundas D, Karatzas N, Moralidis E, et al. Comparative evaluation of 99mTc-depreotide and 201T1 chloride single photon emission tomography in the characterization of pulmonary lesions. Nucl Med Commun, 2007, 28(7):533-540.
[19] Ferran N, Rieart Y, Lopez M, et al. Characterization of radiologieally indeterminate lung lesions:99mTc-depreotide SPECT versus 18F-FDG PET. Nucl Med Commun, 2006, 27(6):507-514.
[20] Chcialowski A, Dziuk E, From S, et al. Technetium99 labelled synthetic somatostatin analogue (depreotide) in the diagnosis of peripheral solitary pulmonary nodules. Pal Arch Med Wewn, 2004, 112(3):1031-1038.
[21] Bååth M, Kölbeek KG, Danielsson R. Somatostatin receptor scintigraphy with 99mTc-Depreotide (NeoSpect) in discriminating between malignant and benign lesions in the diagnosis of lung cancer:a pilot study. Acta Radiol, 2004, 45(8):833-839.
[22] Martins T, Lino JS, Ramos S, et al. 99mTc-depreotide scintigraphy in the evaluation of indeterminate pulmonary lesions:clinical experience. Cancer Biother Radiopharm, 2004, 19(2):253-259.
[23] Kahn D, Menda Y, Kernstine K, et al. The utility of 99mTcdepreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Chest, 2004, 125(2):494-501.
[24] Danielsson R, Baath M, Svensson L, et al. Imaging of regional lymph node metastases with 99mTc-depreotide in patients with lung cancer. Eur J Nucl Med Mol Imaging, 2005, 32(8):925-931.
[25] Mena E, Camacho V, Estorch M, et al. 99mTc-depreotide seintigraphy of bone lesions in patients with lung eaneer. Eur J Nuel Med Mol Imaging, 2004, 31(10):1399-1404.
相似文献/References:
[1]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[2]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[3]张艳兰,孙琦婷,武萍,等.呼吸门控PET/CT对于肺癌放疗靶区勾画的指导[J].国际放射医学核医学杂志,2015,39(2):105.[doi:10.3760/cma.j.issn.1673-4114.2015.02.001]
Zhang Yanlan,Sun Qiting,Wu Ping,et al.Guiding the target delineation in radiation therapy of lung cancer by respiratory gated PET/CT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):105.[doi:10.3760/cma.j.issn.1673-4114.2015.02.001]
[4]张高潮,马丽,寇莹,等.99Tcm-tetrofosmin SPECT诊断肺部肿瘤的临床价值[J].国际放射医学核医学杂志,2015,39(4):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
Zhang Gaochao,Ma Li,Kou Ying,et al.Clinical value of 99Tcm-tetrofosmin SPECT in the diagnosis of lung neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
[5]付畅,史大鹏,徐俊玲,等.不同组织学类型肺癌患者大脑静息葡萄糖代谢改变研究[J].国际放射医学核医学杂志,2014,38(2):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
Fu Chang,Shi Dapeng,Xu Junling,et al.The preliminary study of brain glucose metabolism changes in patients with lung cancer of different histological types[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
[6]张俊涛.晚期肺癌125I粒子植入治疗近期疗效观察[J].国际放射医学核医学杂志,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
Zhang Juntao.Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
[7]杨心蕊,卫华,郝新忠,等.过敏性肺炎伴左肺动脉栓塞18F-FDGPET/CT误诊肺癌一例[J].国际放射医学核医学杂志,2014,38(2):135.[doi:10.3760/cma.j.issn.1673-4114.2014.02.014]
[8]王芹,杜利清,徐畅,等.白细胞介素21基因联合放射对肺癌细胞生长的协同抑制作用[J].国际放射医学核医学杂志,2014,38(3):161.[doi:10.3760/cma.j.issn.1673-4114.2014.02.005]
Wang Qin,Du Liqing,Xu Chang,et al.Synergism inhibition effect of adenovirus-mediated IL-21 gene combined with ionizing radiation on the growth of pulmonary carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):161.[doi:10.3760/cma.j.issn.1673-4114.2014.02.005]
[9]朱同华,杨鸿林,钮丽萍.血浆CYFRA21-1和CA125、CA199、CA153联合检测对肺癌的辅助诊断价值[J].国际放射医学核医学杂志,2014,38(5):304.[doi:10.3760/cma.j.issn.1673-4114.2014.05.007]
Zhu Tong-hua,Yang Hong-lin,Niu Li-ping.The value of combined detection of plasma CYFRA21-1 and CA125, CA199, CA153 in the accessory diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):304.[doi:10.3760/cma.j.issn.1673-4114.2014.05.007]
[10]廖江荣,蒲德利,程毅力,等.经纤支镜和经皮联合植入125I粒子治疗晚期肺癌气管狭窄的临床分析[J].国际放射医学核医学杂志,2013,37(3):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
LIAO Jiang-rong,PU De-li,CHENG Yi-li,et al.The clinical analysis of 125I particles implantation by fibrobronchoscope and percutaneous in the treatment of tracheal stenosis of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]